GAITHERSBURG, Md., Nov. 30, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today
Read more
Home »
Moderna Announces the European Commission’s Approval of Advance Purchase Agreement for Initial 80 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nov. 25, 2020– Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create
Read more
FDA announces safety monitoring measures for the essure device
(HealthDay)—The U.S. Food and Drug Administration is implementing a number of steps for long-term safety monitoring of the permanent birth
Read more
FDA Announces Safety Monitoring Measures for the Essure Device
FRIDAY, Dec. 21, 2018 — The U.S. Food and Drug Administration is implementing a number of steps for long-term safety
Read more